According to a study released on Tuesday, all hormonal contraceptives, including the increasingly popular progestogen-only pills, have a marginally elevated risk of breast cancer.
The study’s authors emphasised that it is important to compare the advantages of hormonal contraceptives, especially the protection they offer against other types of female cancer, against the increased risk of breast cancer.
A higher risk of breast cancer has been linked to two-hormone, or combination, contraceptives, which use both oestrogen and progestogen.
Although research on the associations between progestogen-only contraceptives and breast cancer has been sparse, their use has increased significantly over the past ten years.
